Stockholm, 2013-04-18 13:29 CEST (GLOBE NEWSWIRE) -- In the ongoing small investigator initiated clinical phase IIa trial MANAMI, which examines a PLED substance (mangafodipir) in patients with acute myocardial infarction undergoing coronary angioplasty (PCI), all twenty patients are now included. After analyzing the data, we expect to announce results during 2013.
